Porton Pharma Solutions Ltd. (300363.SZ)
CNY 14.03
(1.37%)
CNY 14.03
(1.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.43 Billion CNY | -63.79% |
| 2022 | 3.65 Billion CNY | 184.61% |
| 2021 | 1.28 Billion CNY | 48.73% |
| 2020 | 863.52 Million CNY | 47.1% |
| 2019 | 587.01 Million CNY | 48.05% |
| 2018 | 396.49 Million CNY | -8.87% |
| 2017 | 435.09 Million CNY | -17.31% |
| 2016 | 526.19 Million CNY | 58.26% |
| 2015 | 332.49 Million CNY | -8.28% |
| 2014 | 362.5 Million CNY | 26.48% |
| 2013 | 286.6 Million CNY | 19.41% |
| 2012 | 240.01 Million CNY | 29.15% |
| 2011 | 185.83 Million CNY | 35.12% |
| 2010 | 137.53 Million CNY | 31.54% |
| 2009 | 104.55 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 101 Million CNY | -2.35% |
| 2024 Q3 | 240.34 Million CNY | 137.96% |
| 2024 Q1 | 103.43 Million CNY | 59.35% |
| 2023 Q4 | 64.9 Million CNY | -78.22% |
| 2023 Q1 | 692 Million CNY | -24.2% |
| 2023 Q3 | 297.96 Million CNY | -26.8% |
| 2023 Q2 | 407.03 Million CNY | -41.18% |
| 2023 FY | 1.32 Billion CNY | -63.79% |
| 2022 Q2 | 1.34 Billion CNY | 90.26% |
| 2022 FY | 3.65 Billion CNY | 184.61% |
| 2022 Q4 | 912.93 Million CNY | 31.78% |
| 2022 Q3 | 692.75 Million CNY | -48.43% |
| 2022 Q1 | 706.11 Million CNY | 77.82% |
| 2021 FY | 1.28 Billion CNY | 48.73% |
| 2021 Q1 | 219.26 Million CNY | -10.62% |
| 2021 Q4 | 397.09 Million CNY | 14.28% |
| 2021 Q3 | 347.46 Million CNY | 8.42% |
| 2021 Q2 | 320.48 Million CNY | 46.17% |
| 2020 FY | 863.52 Million CNY | 47.1% |
| 2020 Q4 | 245.3 Million CNY | -6.05% |
| 2020 Q3 | 261.1 Million CNY | 24.97% |
| 2020 Q2 | 208.93 Million CNY | 41.0% |
| 2020 Q1 | 148.18 Million CNY | -18.2% |
| 2019 Q3 | 173.86 Million CNY | 14.5% |
| 2019 Q4 | 181.15 Million CNY | 4.19% |
| 2019 FY | 587.01 Million CNY | 48.05% |
| 2019 Q1 | 80.14 Million CNY | -29.06% |
| 2019 Q2 | 151.85 Million CNY | 89.47% |
| 2018 Q2 | 106.18 Million CNY | 47.34% |
| 2018 FY | 396.49 Million CNY | -8.87% |
| 2018 Q4 | 112.97 Million CNY | 7.34% |
| 2018 Q3 | 105.25 Million CNY | -0.88% |
| 2018 Q1 | 72.06 Million CNY | -31.69% |
| 2017 Q1 | 141.23 Million CNY | -22.61% |
| 2017 FY | 435.09 Million CNY | -17.31% |
| 2017 Q4 | 105.5 Million CNY | 5.02% |
| 2017 Q3 | 100.45 Million CNY | 14.28% |
| 2017 Q2 | 87.9 Million CNY | -37.76% |
| 2016 Q3 | 91.02 Million CNY | -34.14% |
| 2016 Q2 | 138.21 Million CNY | 20.74% |
| 2016 Q4 | 182.49 Million CNY | 100.49% |
| 2016 FY | 526.19 Million CNY | 58.26% |
| 2016 Q1 | 114.46 Million CNY | 15.17% |
| 2015 FY | 332.49 Million CNY | -8.28% |
| 2015 Q4 | 99.39 Million CNY | 30.1% |
| 2015 Q3 | 76.39 Million CNY | 2.34% |
| 2015 Q2 | 74.64 Million CNY | -9.04% |
| 2015 Q1 | 82.06 Million CNY | -43.9% |
| 2014 Q2 | 65.96 Million CNY | -11.87% |
| 2014 Q1 | 74.85 Million CNY | 21.56% |
| 2014 FY | 362.5 Million CNY | 26.48% |
| 2014 Q4 | 146.28 Million CNY | 94.04% |
| 2014 Q3 | 75.39 Million CNY | 14.29% |
| 2013 Q2 | 54.84 Million CNY | -35.63% |
| 2013 FY | 286.6 Million CNY | 19.41% |
| 2013 Q1 | 85.2 Million CNY | 0.0% |
| 2013 Q3 | 84.97 Million CNY | 54.93% |
| 2013 Q4 | 61.57 Million CNY | -27.54% |
| 2012 FY | 240.01 Million CNY | 29.15% |
| 2011 FY | 185.83 Million CNY | 35.12% |
| 2010 FY | 137.53 Million CNY | 31.54% |
| 2009 FY | 104.55 Million CNY | 0.0% |